Document is current
Any future updates will be listed below
-
Authors
Macarulla, Teresa https://orcid.org/0000-0002-5856-4082
Neuzillet, Cindy https://orcid.org/0000-0001-7037-7477
Prager, Gerald W. https://orcid.org/0000-0002-7854-7781
Rimassa, Lorenza https://orcid.org/0000-0001-9957-3615
Bridgewater, John https://orcid.org/0000-0001-9186-1604
-
Funding
Funding for this research was provided by:
Servier
- License Information
-
More Information
Article History
Received: 23 May 2025
Accepted: 1 August 2025
First Online: 8 October 2025
Declarations
:
: All authors (Teresa Macarulla, Cindy Neuzillet, Gerald W. Prager, Lorenza Rimassa, and John Bridgewater) have received honoraria for consultancy, advisory roles and/or speaker fees from Servier. In addition, Teresa Macarulla has received grants for investigator-initiated studies from Servier, AstraZeneca and Incyte; honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Janssen, Lilly, Esteve, Daiichi Sankyo, Biontech, Novartis and Jazz Pharmaceuticals; and support to travel and/or attend meetings from Servier, AstraZeneca, Sanofi, Incyte, Lilly, MSD and Roche. Cindy Neuzillet has also received honoraria or consultancy fees from Amgen, Astellas, AstraZeneca, AAA, Baxter, Bristol Myers Squibb, Boehringer Ingelheim, Fresenius Kabi, Incyte Biosciences, Merck, MSD, Mundipharma, Nestlé Health Science, Novartis, Nutricia, OSE Immunotherapeutics, Pierre Fabre, Roche, Sanofi, Theradial and Viatris; and clinical research funding from AstraZeneca, Bristol Myers Squibb, Fresenius Kabi, Nutricia, OSE Immunotherapeutics, Roche, Servier and Viatris. Gerald W. Prager has also received fees from Roche, Merck, Sanofi, Lilly, Bayer, Incyte, AstraZeneca, Astellas, MSD, BMS, Arcus, BeiGene and Amgen. Lorenza Rimassa has also received fees for consultancy or advisory roles from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Eisai, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Taiho Oncology and Zymeworks; honoraria for lectures from AstraZeneca, Bayer, BMS, Guerbet, Incyte, Ipsen and Roche; her institution has received research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences and Zymeworks; and she has received travel support from AstraZeneca and Servier.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
